Skip to main content
. 2019 Aug;17(8):787–807. doi: 10.2174/1570159X17666190409142555

Table 4. Sham-controlled studies of DBS in OCD patients.

Study N Age, Years (Range) Female/ Male (N) Design Observation (Months) DBS Target Results/Conclusions
Mallet et al., 2008 [97] 17 43.05 (29-56) 7/10 Randomized, double-blind, crossover study: two 3-month, and a 1-month washout phases 10 Subthalamic nucleus Active (second) vs. sham (first) stimulation of the subthalamic nucleus: Y-BOCS scores was significantly lower.
Goodman et al., 2010 [89] 6 36.2 (27-52) 4/2 Randomized, staggered-onset study: either 30- or 60-days (blind) stimulation following surgery 12 Ventral capsule/ ventral striatum, bilaterally 12 months of active stimulation: response in 66.7% (≥35% Y-BOCS improvement or Y-BOCS severity ≤16).
Sham stimulation: no improvements.
Denys et al., 2010 [95] 16 42.56 (21-59) 7/9 Three sequential treatment phases:
open 8-month treatment phase;
double-blind crossover phase with 2-weeks of active or sham stimulation;
open 12-month maintenance
21 Nucleus accumbens, bilaterally Bilateral nucleus accumbens DBS may be an effective and safe treatment.
Open phase: 46% Y-BOCS decrease; double-blind, sham-controlled phase: active vs. sham treatment showed 25% Y-BOCS score difference
Baas et al., 2014 [92] 8 39.2 (27-60)* 4/4 Double-blind, crossover study; 2-weeks of active or sham stimulation 1 Ventral internal capsule, bilaterally Decrease in OC, anxiety, and depressive symptoms.

*Patients were all from Denys et al. [95]. DBS, deep brain stimulation; Y-BOCS, Yale-Brown Obsessive Compulsive Scale.